+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2015-04-23Number of Pages: 65

Bone Morphogenetic Proteins Market (Types : rhBMP-2 and rhbmp-7; Applications: Spinal Fusion, Trauma, Reconstructive and Oral - Maxillofacial) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2022

 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
     1.3.1 Secondary Research
     1.3.2 Primary Research
1.4 Assumptions
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Bone Morphogenetic Proteins Market (2013 & 2022)
2.2 Global Bone Morphogenetic Proteins Market Revenue, by Types, 2013 (USD Million)
2.3 Global Bone Morphogenetic Proteins Market Revenue, by Applications, 2013 (USD Million)
2.4 Comparative Analysis: Global Bone Morphogenetic Proteins Market Revenue, by Geography, 2013 & 2022 (Value %)
 
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
     3.2.1 Increase in number of spinal fusion surgeries would expedite the demand of BMPs
     3.2.2 Aging population likely to trigger the demand for bone morphogenetic proteins
     3.2.3 Surge in trauma and sports related injuries
     3.2.4 Increasing prevalence of lower back pain would increase the number of spinal surgeries
     3.2.5 Rising demand for minimally invasive surgeries
3.3 Market Restraints
     3.3.1 Off-label usage linked with serious side effects leads to decline in market revenue
     3.3.2 Availability of alternative bone graft substitutes reduces the demand of BMPs
     3.3.3 High cost of BMPs and approval for limited indications limits the market earning
3.4 Market Opportunities
     3.4.1 Emerging countries
3.5 Porter’s Five Force Analysis: Global Bone Morphogenetic Proteins Market
     3.5.1 Bargaining power of suppliers
     3.5.2 Bargaining power of buyers
     3.5.3 Threat of new entrants
     3.5.4 Threat of substitutes
     3.5.5 Competitive rivalry
3.6 Market Attractiveness Analysis: Global Bone Morphogenetic Proteins Market, by Geography, 2013
3.7 Regulatory Framework
3.8 Value Chain Analysis
3.9 Competitive Landscape
     3.9.1 Global Bone Morphogenetic Proteins Market Share Analysis, by Key Players, 2013 (Value %)
3.10 Global Orthobiologics Market Revenue, by Types, 2012 – 2022 (USD Million)
 
Chapter 4 Bone Morphogenetic Proteins Market, by Types
4.1 Overview
     4.1.1 Global Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
4.2 Average Pricing Analysis
4.3 Recombinant human bone morphogenetic protein-2 (rhBMP-2)
     4.3.1 Global rhBMP-2 Market Revenue, 2012 – 2022 (USD Million)
4.4 Recombinant human bone morphogenetic protein-7 (rhBMP-7)
     4.4.1 Global rhBMP-7 Market Revenue, 2012 – 2014 (USD Million)
 
Chapter 5 Bone Morphogenetic Proteins Market, by Application
5.1 Overview
     5.1.1 Global Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
5.2 Spinal Fusion
     5.2.1 Global Spinal Fusion Market Revenue,2012–2022 (USD Million)
5.3 Trauma
     5.3.1 Global Trauma Market Revenue,2012–2022 (USD Million)
5.4 Reconstructive Surgery
     5.4.1 Global Reconstructive Surgery Market Revenue,2012–2022 (USD Million)
5.5 Oral-Maxillofacial
     5.5.1 Global Oral-Maxillofacial Market Revenue,2012–2022 (USD Million)
 
Chapter 6 Bone Morphogenetic Proteins Market, by Geography
6.1 Overview
     6.1.1 Global Bone Morphogenetic Proteins Market Revenue, by Geography, 2012 – 2022 (USD Million)
6.2 North America
     6.2.1 North America Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
     6.2.2 North America Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
6.3 Europe
     6.3.1 Europe Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
     6.3.2 Europe Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
6.4 Asia-Pacific
     6.4.1 Asia-Pacific Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
     6.4.2 Asia-Pacific Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
6.5 Rest of the World
     6.5.1 RoW Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
     6.5.2 RoW Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
 
Chapter 7 Recommendation
7.1 Success strategies
     7.1.1 Introduction of new indication, carriers and formulations for BMP products
     7.1.2 Investing in emerging economies
 
Chapter 8 Company Profiles
8.1 Cellumed Co, Ltd.
     8.1.1 Company Overview
     8.1.2 Financial Overview
     8.1.3 Product Portfolio
     8.1.4 Business Strategies
     8.1.5 Recent Developments
8.2 Medtronic plc
     8.2.1 Company Overview
     8.2.2 Financial Overview
     8.2.3 Product Portfolio
     8.2.4 Business Strategies
     8.2.5 Recent Developments
8.3 Stryker Corporation
     8.3.1 Company Overview
     8.3.2 Financial Overview
     8.3.3 Product Portfolio
     8.3.4 Business Strategies
     8.3.5 Recent Developments

List of Figures
 
FIG. 1 Bone Morphogenetic Proteins: Market Segmentation
FIG. 2 Global Bone Morphogenetic Proteins Market, by Types, 2013 (USD Million)
FIG. 3 Global Bone Morphogenetic Proteins Market, by Applications, 2013 (USD Million)
FIG. 4 Comparative Analysis: Global Bone Morphogenetic Proteins Revenue, by Geography, 2013 & 2022 (Value %)
FIG. 5 Porter’s Five Force Analysis: Global Bone Morphogenetic Proteins Market
FIG. 6 Market Attractiveness Analysis: Global Bone Morphogenetic Proteins Market, by Geography
FIG. 7 Value Chain: Global Bone Morphogenetic Proteins Market
FIG. 8 Global Bone Morphogenetic Protein Market Share Analysis, by Key Players, 2013 (Value %)
FIG. 9 Global rhBMP-2 Market Revenue, 2012 - 2022 (USD Million)
FIG. 10 Global rhBMP-7 Market Revenue, 2012 - 2014 (USD Million)
FIG. 11 Global Spinal Fusion Market Revenue, 2012 – 2022 (USD Million)
FIG. 12 Global Trauma Market Revenue, 2012 – 2022 (USD Million)
FIG. 13 Global Reconstructive Surgery Market Revenue, 2012 – 2022 (USD Million)
FIG. 14 Global Oral-Maxillofacial Market Revenue, 2012 – 2022 (USD Million)
FIG. 15 Medtronic, Inc.: Annual Revenue, 2012 - 2014 (USD Million)
FIG. 16 Stryker Corporation: Annual Revenue, 2012– 2014 (USD Million)

List of Tables
 
TABLE 1 Market Snapshot: Global Bone Morphogenetic Proteins Market (2013 & 2022)
TABLE 2 Global Orthobiologics Market Revenue, by Types, 2012 – 2022 (USD Million)
TABLE 3 Global Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
TABLE 4 Global Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
TABLE 5 Global Bone Morphogenetic Proteins Market Revenue, by Geography, 2012 – 2022 (USD Million)
TABLE 6 North America Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
TABLE 7 North America Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
TABLE 8 Europe Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
TABLE 9 Europe Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
TABLE 10 Asia-Pacific Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
TABLE 11 Asia-Pacific Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)
TABLE 12 RoW Bone Morphogenetic Proteins Market Revenue, by Types, 2012 – 2022 (USD Million)
TABLE 13 RoW  Bone Morphogenetic Proteins Market Revenue, by Applications, 2012 – 2022 (USD Million)


 
 
Back To Top